-

PL Developments Builds a Smarter, Healthier Supply Chain with Kinaxis

Leading pharmaceuticals manufacturer will utilize AI-powered orchestration to accelerate delivery of essential health products

OTTAWA, Ontario--(BUSINESS WIRE)--Kinaxis® (TSX:KXS), a global leader in end-to-end supply chain orchestration, today announced that PL Developments (PLD), a leading manufacturer and distributer of over-the-counter pharmaceuticals and healthcare products, has selected the Kinaxis Maestro™ platform to meet growing demand from consumers and major U.S. retailer partners. By replacing manual tools and spreadsheets with AI-powered orchestration and predictive planning, PLD will accelerate the delivery of essential healthcare products with greater agility, accuracy and efficiency.

“With Maestro, they’re not just replacing spreadsheets, they’re unlocking real-time visibility, rapid execution and scalable decision making."

Share

Specializing in end-to-end solutions from product development to distribution, PLD supplies some of the largest retailers in the U.S. including Walmart, Walgreens, CVS, Costco, Sam’s Club and Target with health and wellness products in categories including analgesics, cough/cold, allergy and digestive. Due to market expansion and rapidly increasing consumer demand for accessible and affordable healthcare products, PLD needed to deliver to its retail partners with greater speed, accuracy and responsiveness. With manual planning tools and siloed decision-making, PLD was challenged by limited visibility across its operations leading to delayed order confirmations and high inventory levels.

To maintain its position as a trusted industry leader, PLD needed a next-generation supply chain platform to meet evolving customer expectations while continuing to deliver on the promise of quality at every step. After rigorous evaluation, Maestro stood out for its unmatched ability to unify data and provide real-time insights, enabling predictive planning to anticipate demand. Maestro allows PLD to optimize inventory, respond faster to market shifts and scale execution across every function of the business with fewer resources and greater supply chain visibility.

“Consumers expect fast access to trusted health and wellness products, and our retail partners need the inventory to match shifting demand,” said Thomas Crowe, chief supply chain officer at PL Developments. “With Maestro, we can anticipate this demand, simulate scenarios, plan for market shifts and make confident, data-driven decisions in minutes. It’s a game changer that empowers our team to deliver the innovation and products consumers rely on every single day and Kinaxis is now a key part of that innovation.”

“PLD is a prime example of a forward-thinking manufacturer embracing the speed and intelligence today’s healthcare supply chains demand,” said Mark Morgan, president of global commercial operations at Kinaxis. “With Maestro, they’re not just replacing spreadsheets, they’re unlocking real-time visibility, rapid execution and scalable decision making. We’re proud to support PLD as they deliver the trusted healthcare products consumers rely on, faster and more efficiently than ever.”

To learn more about Kinaxis and its supply chain management solutions, please visit Kinaxis.com.

About Kinaxis

Kinaxis is a global leader in modern supply chain orchestration, powering complex global supply chains and supporting the people who manage them, in service of humanity. Our powerful, AI-infused supply chain orchestration platform, Maestro™ combines proprietary technologies and techniques that provide full transparency and agility across the entire supply chain — from multi-year strategic planning to last-mile delivery. We are trusted by renowned global brands to provide the agility and predictability needed to navigate today’s volatility and disruption. For more news and information, please visit kinaxis.com or follow us on LinkedIn.

Source: Kinaxis Inc

Contacts

Media Relations
Erin Boyle | Kinaxis
eboyle@kinaxis.com
+1 519-574-4065

Investor Relations
Rick Wadsworth | Kinaxis
rwadsworth@kinaxis.com
+1 613-907-7613

Kinaxis Inc.

TSX:KXS


Contacts

Media Relations
Erin Boyle | Kinaxis
eboyle@kinaxis.com
+1 519-574-4065

Investor Relations
Rick Wadsworth | Kinaxis
rwadsworth@kinaxis.com
+1 613-907-7613

Social Media Profiles
More News From Kinaxis Inc.

71% of Global Businesses Have Accelerated AI Adoption Amid Tariffs, Inflation and Uncertainty, Finds Economist Study Commissioned by Kinaxis

OTTAWA, Ontario--(BUSINESS WIRE)--According to Supply Chain’s Big Bet on AI For Geopolitical Resilience, a new global study from Economist Impact, commissioned by Kinaxis® Inc. (TSX:KXS), while 71% of companies have accelerated AI deployment in response to tariffs, inflation, and geopolitical volatility, a wide gap remains between AI ambition and implementation, according to Economist Impact. Nearly every company (97%) is experimenting with AI, but only 20% can make real-time decisions, and jus...

Kinaxis Inc. Reports Third Quarter 2025 Results

OTTAWA, Ontario--(BUSINESS WIRE)--Kinaxis® (TSX:KXS), a global leader in end-to-end supply chain orchestration, reported results for its third quarter ended September 30, 2025. All amounts are in U.S. dollars. All figures are prepared in accordance with International Financial Reporting Standards (IFRS) unless otherwise indicated. “Our momentum continues as record new business for a third quarter drove accelerated ARR growth and allows us to confidently target even stronger results for fiscal 2...

Kinaxis Announces Normal Course Issuer Bid

OTTAWA, Ontario--(BUSINESS WIRE)--Kinaxis® Inc. (“Kinaxis” or the “Company”) (TSX: KXS) is pleased to announce that the Toronto Stock Exchange (the “TSX”) has accepted a notice (the “Notice”) filed by the Company of its intention to make a normal course issuer bid (the “NCIB”). In connection with the NCIB, the Company has entered into an automatic share purchase plan (an “ASPP”) with its designated broker to allow for purchases of its common shares (the “Shares”). The Notice provides that the C...
Back to Newsroom